Explore › Condition › Anxiety
Condition

Anxiety

Also known as: Angst Anxiety Anxiety (finding) Anxiety reaction Anxiousness Anxiousness (& symptom) Anxiousness (& symptom) (finding) Anxiousness - symptom Feeling anxious anxiety; HIV
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
nicotine metabolism1
outcomes
Anxiety symptoms1
studys
PMC63312371

Findings (27)

None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →
None
decline

Higher nicotine metabolite ratio was significantly associated with higher anxiety symptoms among HIV-positive smokers in univariate analysis and marginally in the multivariate model.

Effect: decline; r = .26, p = .003 (univariate); b = 0.191, p = .054 (multivariate)

Size: r = .26, p = .003 (univariate); b = 0.191, p = .054 (multiva
PMC6331237
Finding details → · Paper → · Graph →

Papers (1)